AIMS: To examine cannabis use among mid-adolescents in 31 countries and associations with per-capita personal consumer expenditure (PCE), unemployment, peer factors and national rates of cannabis use in 1999. DESIGN, PARTICIPANTS AND MEASUREMENT: Nationally representative, self-report, classroom survey with 22 223 male and 24 900 female 15-year-olds. Country characteristics were derived from publicly available economic databases and previously conducted cross-national surveys on substance use. FINDINGS: Cannabis use appears to be normative among mid-adolescents in North America and several countries in Europe. The life-time prevalence of cannabis use was 26% among males and 15% among females and was lowest for males and females in the former Yugoslav Republic (TFYR) of Macedonia: 2.5% and to 2.5%, respectively; and highest for males in Switzerland (49.1%) and in Greenland for females (47.0%). The highest prevalence of frequent cannabis use (more than 40 times in life-time) was seen in Canada for males (14.2%) and in the United States for females (5.5%). Overall, life-time prevalence and frequent use are associated with PCE, perceived availability of cannabis (peer culture) and the presence of communities of older cannabis users (drug climate). CONCLUSIONS: As PCE increases, cannabis use may be expected to increase and gender differences decrease. Cross-national comparable policy measures should be developed and evaluated to examine which harm reduction strategies are most effective.
AIMS: To examine cannabis use among mid-adolescents in 31 countries and associations with per-capita personal consumer expenditure (PCE), unemployment, peer factors and national rates of cannabis use in 1999. DESIGN, PARTICIPANTS AND MEASUREMENT: Nationally representative, self-report, classroom survey with 22 223 male and 24 900 female 15-year-olds. Country characteristics were derived from publicly available economic databases and previously conducted cross-national surveys on substance use. FINDINGS: Cannabis use appears to be normative among mid-adolescents in North America and several countries in Europe. The life-time prevalence of cannabis use was 26% among males and 15% among females and was lowest for males and females in the former Yugoslav Republic (TFYR) of Macedonia: 2.5% and to 2.5%, respectively; and highest for males in Switzerland (49.1%) and in Greenland for females (47.0%). The highest prevalence of frequent cannabis use (more than 40 times in life-time) was seen in Canada for males (14.2%) and in the United States for females (5.5%). Overall, life-time prevalence and frequent use are associated with PCE, perceived availability of cannabis (peer culture) and the presence of communities of older cannabis users (drug climate). CONCLUSIONS: As PCE increases, cannabis use may be expected to increase and gender differences decrease. Cross-national comparable policy measures should be developed and evaluated to examine which harm reduction strategies are most effective.
Authors: R F Farmer; D B Kosty; J R Seeley; S C Duncan; M T Lynskey; P Rohde; D N Klein; P M Lewinsohn Journal: Psychol Med Date: 2014-05-12 Impact factor: 7.723
Authors: Julia P Schleimer; Ariadne E Rivera-Aguirre; Alvaro Castillo-Carniglia; Hannah S Laqueur; Kara E Rudolph; Héctor Suárez; Jessica Ramírez; Nora Cadenas; Matías Somoza; Maria V Brasesco; Silvia S Martins; Magdalena Cerdá Journal: Drug Alcohol Depend Date: 2019-06-12 Impact factor: 4.492
Authors: Silvia S Martins; Christine M Mauro; Julian Santaella-Tenorio; June H Kim; Magdalena Cerda; Katherine M Keyes; Deborah S Hasin; Sandro Galea; Melanie Wall Journal: Drug Alcohol Depend Date: 2016-10-11 Impact factor: 4.492
Authors: Tom F M ter Bogt; Margreet de Looze; Michal Molcho; Emmanuelle Godeau; Anne Hublet; Anna Kokkevi; Emmanuel Kuntsche; Saoirse Nic Gabhainn; Iva Pejnovic Franelic; Bruce Simons-Morton; Sharon Sznitman; Alessio Vieno; Wilma Vollebergh; William Pickett Journal: Addiction Date: 2013-11-22 Impact factor: 6.526
Authors: Marianna Virtanen; Minna Pietikäinen; Mika Kivimäki; Pauliina Luopa; Jukka Jokela; Marko Elovainio; Jussi Vahtera Journal: BMC Public Health Date: 2009-10-09 Impact factor: 3.295